Last reviewed · How we verify

Peppermint sweets

St. Antonius Hospital · Phase 3 active Small molecule

Peppermint sweets provide symptomatic relief through the cooling and soothing properties of menthol, which activates TRPM8 receptors to produce a refreshing sensation in the oral cavity and throat.

Peppermint sweets provide symptomatic relief through the cooling and soothing properties of menthol, which activates TRPM8 receptors to produce a refreshing sensation in the oral cavity and throat. Used for Symptomatic relief of minor throat irritation and cough.

At a glance

Generic namePeppermint sweets
Also known asWilhelmina®
SponsorSt. Antonius Hospital
TargetTRPM8 receptor
ModalitySmall molecule
Therapeutic areaConsumer Health / Symptomatic Relief
PhasePhase 3

Mechanism of action

Menthol, the active compound in peppermint, binds to transient receptor potential melastatin 8 (TRPM8) channels, creating a cooling sensation that can help soothe minor throat irritation and provide temporary symptomatic relief. The mechanism is primarily sensory rather than pharmacological, making peppermint sweets a consumer health product rather than a traditional pharmaceutical agent.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: